Search results
Sensex, Nifty at record highs again! From strategy to preferred sectors, experts advise how to...
Livemint· 4 hours agoThe Sensex rose 406 points to its new high of 80,392.64 while the broader Nifty gained 114.5 points...
Infosys Ltd Director Discussions | India Infoline
India Infoline· 5 hours agoThe Board of Directors hereby submits the report of the business and operations of your Company ("the Company" or "Infosys"), along with the audited financial ...
Shares of this 'Miniratna' PSU surge over 8% to near record levels after its Q1 business update -...
CNBC TV18· 1 day agoThe company in an exchange filing on Tuesday said that it registered record quarterly sales and production figures since its inception. Sales for the April-June quarter grew ...
Rs 256 to Rs 1,774: This IT stock turned into a multibagger in three years, hit record high today
Business Today· 49 minutes agoShares of KPIT Technologies have clocked multibagger returns in the last three years. The...
What to buy? Keep good company, go for large caps - Times of India
The Times of India· 8 hours agoMUMBAI: The sensex has recorded a new high. Well, as veteran investor Peter Lynch famously put it:...
Asian Paints Auditor Reports: Latest Updates and Details | India Infoline
India Infoline· 1 day agoKey audit matters are those matters that, in our professional judgement, were of most significance in our audit of the Standalone...
Rupee falls 5 paise to 83.53 against US dollar in early trade
The Telegraph· 1 day agoOn Tuesday, the local unit depreciated 4 paise to settle at 83.48 against the American currency
Nifty 50 Share Price Live Updates: Nifty 50 is trading at ₹24292.5
Livemint· 23 hours agoNifty 50 Share Price Live Updates: At 16:45 Nifty 50 was trading at 24286.5 (0.67%). Today Nifty 50 has been trading in the range of 24309.15 to 24207.1.
AI deals lift US venture capital funding to highest level in two years, data shows - ET Telecom
The Economic Times· 1 day agoInvestors' ongoing excitement around building and adopting AI technology, which could potentially...
5 FDA decisions to watch in the third quarter
BioPharma Dive· 1 day agoMultibillion-dollar buyouts from Bristol Myers Squibb and Gilead could yield new drugs for brain and liver diseases, while a new cell therapy may reach...